CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 361 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01145053
NCT01145053N/ACompleted

Long Time Survey of RESPIMAT in Daily Clinical Use

Boehringer Ingelheim·observational·Posted Jun 16, 2010·Updated Mar 27, 2014

In Brief

An observational study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 361 participants.

Detailed Summary

To investigate safety and effectiveness information on the use of Tiotropium Respimat for long time of period in daily practical clinical circumstances, and to obtain proper drug use information.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 16, 2010
Enrollment StartMay 1, 2010
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 16.0 years ago